Sickle Cell Disease in the Sudan: Clinical and Biochemical Aspects

References

• Abu-Zeid Y A, Theander T G, Abdulhadi N H, et al. Modulation of the cellular immune response during Plasmodium falciparum infections in sickle cell trait individuals. Clin Exp Immunol 1992; 88: 112–118
   Google Scholar
• Adekile A D, Kitundu M N, Gu L-H, Lanclos K D, Adeodu O O, Huisman T HJ. Haplotypes in SS patients from Nigeria; characterization of one atypical βs haplotype no. 19 (Benin) associated with elevated Hb F and high Ggamma levels. Ann Hematol 1992; 65: 41–45
   PubMed Web of Science ®Google Scholar
• Ahmed H A, Baker E A. Sickling in the Sudan; Result of surveys in Blue Nile Province. East Afr Med J 1986; 6: 395–399
   Google Scholar
• Allan D, Limbrick A R, Thomas P, Westerman M P. Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature 1982; 295: 612–613
   PubMedGoogle Scholar
• Allon M. Renal abnormalities in sickle cell disease. Arch Intern Med 1990; 150: 501–504
   PubMedGoogle Scholar
• Alter B P. Prenatal diagnosis of haemoglobinopathies: a status report. Lancet 1981; 2: 1152–1154
   PubMed Web of Science ®Google Scholar
• Aluoch J R, Kliniç Y, Aksoy M, et al. Sickle cell anaemia among Eti-Turks: haematological, clinical and genetic observations. Br J Haematol 1986; 64: 45–55
   PubMed Web of Science ®Google Scholar
• Asakura T, Minakata K, Adachi K, Russell M O, Schwarts E. Denatured hemoglobin in sickle erythrocytes. J Clin Invest 1977; 59: 633–640
   PubMed Web of Science ®Google Scholar
• Bailey K, Morris J S, Thomas P, Serjeant G R. Fetal haemoglobin and early manifestations of homozygous sickle cell disease. Arch Dis Child 1992; 67: 517–520
   PubMed Web of Science ®Google Scholar
• Bainbridge R, Higgs D R, Maude G H, Serjeant G R. Clinical presentation of homozygous sickle cell disease. J Pediatr 1985; 106(6)881–885
   PubMed Web of Science ®Google Scholar
• Ballas S, Smith E D. Red blood cell changes during the evolution of the sickle cell painful crisis. Blood 1992; 79(8)2154–2163
   PubMed Web of Science ®Google Scholar
• Bayoumi R A. The sickle cell trait modifies the intensity and specificity of the immune response against P. falciparum malaria and leads to acquired protective immunity. Med Hypotheses 1987; 22: 287–298
   PubMed Web of Science ®Google Scholar
• Bayoumi R A, Abu Zeid Y A, Abdul Sadig A, Awad Elkarim O. Sickle cell disease in Sudan. Trans Roy Soc Trop Med Hyg 1988; 82: 164–168
   PubMed Web of Science ®Google Scholar
• Benjamin G C. Sickle cell trait and sickle cell anemia: A review. Military Medicine 1983; 148: 701–706
   Google Scholar
• Bennet V. The membrane skeleton of human erythrocytes and its implication for more complex cell. Ann Rev Biochem 1985; 54: 273–304
   PubMed Web of Science ®Google Scholar
• Bergmeyer H U. Methods of enzymatic analysis, 3rd edn. Verlag Chemie, Weinheim 1983; 2: 211–213
   Google Scholar
• Bjomson A B, Lobel J S. Lack of a requirement for the Fc region of IgG in restoring pneumococcal opsonization via the alternative complement pathway in sickle cell disease. J Infect Dis 1986; 154(5)760–769
   Google Scholar
• Bjornson A B, Lobel J S. Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency. J Clin Invest 1987; 79: 388–398
   Google Scholar
• Bookchin R M, Ortiz O E, Lew V L. Silent intracellular calcium in sickle cell anaemia red cells. Prog Clin Biol Res 1984; 165: 17–28
   Google Scholar
• Bookchin R M, Ortiz O E, Somlyo A V, et al. Calcium accumulating inside-out vesicles in sickle cell anaemia red cells. Trans Assoc Am Physicians 1985; 98: 10–20
   Google Scholar
• Bookchin R M, Ortiz O E, Lew V L. Activation of calcium-dependent potassium channels in deoxygenated sickled red cells. Prog Clin Biol Res 1987; 240: 193–200
   Google Scholar
• Buckalew V M, Someren A. Renal manifestations of sickle cell disease. Arch Int Med 1974; 133: 660–669
   PubMedGoogle Scholar
• Charache S, Dover G J, Moore R D, et al. Hydroxyurea: Effects on hemoglobin F production in patients with sickle cell anemia. Blood 1992; 79(10)2555–2565
   PubMed Web of Science ®Google Scholar
• Chudwin D S, Korenblit A D, Kingzette M, Artrip S, Rao S. Increased activation of the alternative complement pathway in sickle cell disease. Clin Immunol Immunopathol 1985; 37: 93–97
   PubMedGoogle Scholar
• Practical Haematology, J V Dacie, S M Lewis. Churchill Livingstone, Edinburgh 1986
   Google Scholar
• Dean J, Schechter A N. Sickle cell anaemia: Molecular and cellular bases of therapeutic approaches. N Engl J Med 1978; 299(14)752–763
   Google Scholar
• De Ceulaer K, Pagliuca A, Forbes M, Maude G H, Serjeant B E, Serjeant G R. Recurrent infections in sickle cell disease: haematological and immunological studies. Clin Chim Acta 1985; 148: 161–165
   PubMed Web of Science ®Google Scholar
• Dodge J T, Mitchell C, Hanahan D J. Preparation and chemical characterization of hemoglobin free ghosts of human erythrocytes. Arch Biochem Biophys 1963; 34: 283–288
   Google Scholar
• Dzandu J K, Johnson R M. Membrane protein phosphorylation in intact normal and sickle cell erythrocytes. J Biol Chem 1980; 255(13)6382–6386
   Google Scholar
• Eaton W A, Hofrichter J. Hemoglobin S gelation and sickle cell disease. Blood 1987; 70(5)1245–1266
   PubMed Web of Science ®Google Scholar
• Evans E A, Mohandas N. Membrane-associated sickle hemoglobin: a major determinant of sickle erythrocyte rigidity. Blood 1987; 70(5)1443–1449
   Google Scholar
• Falk R J, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette J C. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 1992; 326(14)910–915
   PubMed Web of Science ®Google Scholar
• Fleming A F. The presentation, management and prevention of crisis in sickle cell disease in Africa. Blood Rev 1989; 3: 18–28
   PubMed Web of Science ®Google Scholar
• Foy H, Kondi A, Timms G L, Brass W, Bushra F. The variability of sickle cell rates in the tribes of Kenya and the southern Sudan. Br Med J 1954; 1: 294–297
   PubMedGoogle Scholar
• Franck P FH, Chiu DT-Y, Kamp J AF, Lubin B, van Deenen L LM, Roelofsen B. Accelerated transbilayer movement of phosphatidylcholine in sickled erythrocytes. J Biol Chem 1983; 258(13)8435–8442
   Google Scholar
• Franck P FH, Bevers E M, Lubin B H, et al. Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells. J Clin Invest 1985; 75: 183–190
   PubMed Web of Science ®Google Scholar
• Freidman M J. Erythrocytic mechanism of sickle cell resistance to malaria. Proc Natl Acad Sci USA 1978; 75(4)1994–1997
   Google Scholar
• Gaston M H, Verier J I, Woods G, et al. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N Engl J Med 1986; 314(25)1593–1599
   PubMed Web of Science ®Google Scholar
• Gini E K, Sonnet J. Use of piracetam improves sickle cell deformability in vitro and in vivo. J Clin Pathol 1987; 40: 99–102
   Google Scholar
• Glader B E, Nathan D G. Cation permeability alteration during sickling: relationship to cation composition and cellular hydration of irreversibly sickled cells. Blood 1978; 51(5)983–989
   Google Scholar
• Hassan M M. Haemoglobinopathies in Sudanese children. Sudan Med J 1970; 8(3)160–168
   Google Scholar
• Hebbel R P, Yamada O, Moldow C F, Jacob H S, White J G, Eaton J W. Abnormal adherence of sickle erythrocytes to the cultured vascular endothelium. J Clin Invest 1980; 65: 154–160
   PubMed Web of Science ®Google Scholar
• Hebbel R P, Eaton J W. Sickle cell disease: Beyond the hemoglobin abnormality. Prog Clin Biol Res 1982; 97: 341–349
   Google Scholar
• Hebbel R P, Eaton J W, Balasingam M, Steinberg M. Spontaneous oxygen radical generation by sickle erythrocytes. J Clin Invest 1982; 70: 1253–1259
   PubMed Web of Science ®Google Scholar
• Hebbel R P, Schwarts R S, Mohandas N. The adhesive sickle erythrocyte: cause and consequence of abnormal interactions with endothelium, monocytes, macrophages and model membranes. Clinic Haematol 1985; 14(1)141–161
   Google Scholar
• Herrick J B. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch Inter Med 1910; 6: 517–521
   Google Scholar
• Hill A VS, Allsopp C EM, Kwiatkowski D, et al. Common west African HLA antigens associated with protection from severe malaria. Nature 1991; 352: 595–600
   PubMed Web of Science ®Google Scholar
• Heukeshoven J, Dernick R. Increased sensitivity for coomassie staining of sodium dodecyl sulfate polyacrylamide gels using Phast System development unit. Electrophoresis 1988; 9: 60–61
   PubMedGoogle Scholar
• Jain A P, Chaubey B S, Khan N, Tyagi N K, Gomber A. Study in immune responsiveness in adult asymptomatic sickle cell haemoglobinopathy in rural Central India. Indian J Pathol Microbiol 1988; 31(2)17–20
   PubMedGoogle Scholar
• Jensen W N, Rucknagel D L, Taylor W J. In vivo study of sickle phenomenon. J Lab Clin Med 1960; 56(6)854–865
   Google Scholar
• Johnston R B, Newman S L, Struth A G. An abnormality of the alternative pathway of complement activation in sickle cell disease. N Engl J Med 1973; 288(16)803–808
   PubMed Web of Science ®Google Scholar
• Kaine W N. Sickle cell anaemia in children in eastern Nigeria. A detailed analysis of 210 cases. East Afr Med J 1982; 59(11)742–749
   PubMed Web of Science ®Google Scholar
• Kan Y W, Dozy A M. Antenatal diagnosis of sickle cell anemia by DNA analysis of amniotic fluid cells. Lancet 1978; 2: 910–912
   PubMed Web of Science ®Google Scholar
• Kannan R, Labotka R, Low P S. Isolation and characterization of the hemichrome-stabilized membrane protein aggregates from sickle erythrocytes. J Biol Chem 1988; 263(27)13766–13773
   PubMedGoogle Scholar
• Kasili E G, Bwibo N O. Hematological observations in Kenyan children with sickle cell anemia in the first decade of life. Am J Pediatr Hematol/Oncol 1982; 4(2)182–186
   Google Scholar
• Kaul D K, Fabry M E, Nagel R L. Vaso-occlusion by sickle cells: Evidence for selective trapping of dense red cells. Blood 1986; 68(5)1162–1166
   PubMed Web of Science ®Google Scholar
• Kaul R K, Köhler H. Interaction of hemoglobin with band 3: a review. Klin Wochenschr 1983; 61: 831–837
   PubMedGoogle Scholar
• Konotey-Ahulu F ID. Malaria and sickle cell disease. Br Med J 1971; ii: 710–711
   Web of Science ®Google Scholar
• Kurantsin-Mills J, Klug P P, Lessin L S. Vaso-occlusion in sickle cell disease: Pathophysiology of the microvascular circulation. Am J Pediatr Hematol/Oncol 1988; 10(4)357–372
   Google Scholar
• Kuross S, Rank B H, Hebbel R P. Excess heme in sickle erythrocyte inside-out membranes: possible role in thiol oxidation. Blood 1988; 71(4)876–882
   Google Scholar
• Lauder J R, Ibrahim S A. Sickling in south-west Kordofan. Sudan M J 1970; 8(4)206–214
   Google Scholar
• Leikin S L, Gallagher D, Kinney T R, et al. Mortality of children and adolescents with sickle cell disease. Pediatrics 1989; 84(3)500–508
   PubMed Web of Science ®Google Scholar
• Lew V L, Hockaday A, Sepulveda M-I, et al. Compartmentalization of sickle-cell calcium in endocytic inside-out vesicles. Nature 1985; 315: 586–589
   PubMed Web of Science ®Google Scholar
• Ley T J, DeSimone J, Anagnou N P, et al. 5-azacytidine selectively increases gamma-globin synthesis in a patient with β+ thalassemia. N Engl J Med 1982; 307(24)1469–1475
   PubMed Web of Science ®Google Scholar
• Lonsdorfer A, Coraoe L, Yapo A E, Lansdorfer J. Proteinuria in sickle cell trait and disease: an electrophoretic analysis. Clin Chim Acta 1989; 181: 239–248
   Google Scholar
• Luzzatto L. Genetic factors in malaria. Bull WHO 1974; 50: 195–202
   PubMed Web of Science ®Google Scholar
• Luzzatto L. Genetics of red cells and susceptibility to malaria. Blood 1979; 54(5)961–976
   Google Scholar
• Luzzatto L. Sickle cell anaemia in tropical Africa. Clinics Haematol 1981; 10(3)757–784
   Google Scholar
• Lukens J N. Sickle cell disease. Disease-a-month 1981; 27(5)1–55
   Google Scholar
• Manrique R. Sickle cell anemia. Pathophysiological role of increased intracorpuscular calcium and changes during treatment with pentoxifylline. La Ricerca Clin Lab 1987; 17: 355–362
   Google Scholar
• Marotta C A, Wilson J T, Forget B G, Weissman S M. Human β-globin messenger RNA III. Nucleotide sequences derived from complementary DNA. J Biol Chem 1977; 252: 5040–5051
   PubMedGoogle Scholar
• Middelkoop E, Lubin B H, Bevers E M, et al. Studies on sickled erythrocytes provide evidence that the asymmetric distribution of phosphatidylserine in the red cell membrane is maintained by both ATP-dependent translocation and interaction with membrane skeletal proteins. Biochim Biophys Acta 1988; 937: 281–288
   PubMed Web of Science ®Google Scholar
• Miller B A, Platt O, Hope S, Dover G, Nathan D G. Influence of hydroxyurea on fetal hemoglobin production in vitro. Blood 1987; 70(6)1824–1829
   Google Scholar
• Mohamed A O, Bayoumi R A, Hofvander Y, Omer M IA, Ronquist G. Sickle cell anaemia in Sudan: clinical findings, haematological and serum variables. Ann Trop Paediatr 1992; 12: 131–136
   PubMed Web of Science ®Google Scholar
• Mohamed A O, Ronquist G. Reduction in band 3 protein of red cells in sickle cell anaemia. Upsala J Med Sci. 1991; 96: 23–33
   PubMed Web of Science ®Google Scholar
• Mohamed A O, Ronquist G, Bayoumi R A. Increased membrane activity of glyceraldehyde 3-phosphate dehydrogenase in erythrocytes of patients with homozygous sickle cell anaemia. Clin Chim Acta 1992; 209: 189–195
   Google Scholar
• Mohamed A O, Nilsson U R, Omer M IA, Ronquist G. Lack of evidence for altered complement and immunoglobulin levels in patients with sickle cell anaemia. Scand J Clin Lab Invest 1992; 52: 313–316
   PubMed Web of Science ®Google Scholar
• Molineaux L, Fleming A F, Cornille-Brogger R, Kagan I. Abnormal hemoglobins in the Sudan savanna of Nigeria: malaria immunoglobulins and antimalarial antibodies in sickle cell disease. Ann Trop Med Parasitol 1979; 73(4)301–310
   PubMed Web of Science ®Google Scholar
• Mozzarelli A, Hofrichter J, Eaton W A. Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo. Science 1987; 237: 500–506
   PubMed Web of Science ®Google Scholar
• Murphy E, Berkowitz L R, Orringer E, Levy L, Gabel S A, London R E. Cytosolic free calcium levels in sickle red blood cells. Blood 1987; 69(5)1469–1474
   Google Scholar
• Nagel R L, Fleming A F. Genetic epidemiology of the βs gene. Bailliere's Clin Haematol 1992; 5(2)331–365
   PubMedGoogle Scholar
• Natta C L, Outschoorn I M. IgG2 deficiency in sickle cell anaemia. Scand J Haematol 1984; 33: 129–134
   PubMedGoogle Scholar
• Nilsson U R, Nilsson B. Simplified assays of hemolytic activity of the classical and alternative complement pathway. J Immunol Methods 1984; 72: 49–59
   PubMed Web of Science ®Google Scholar
• Noguchi C T, Rodgers G P, Serjeant G, Schechter A N. Levels of fetal hemoglobin necessary for treatment of sickle cell disease. N Engl J Med 1988; 318(2)96–99
   Google Scholar
• Ohnishi S T. Inhibition of the in vitro formation of irreversibly sickled cells by cepharanthine. Br J Haematol 1983; 55: 665–671
   Google Scholar
• Ojwang P J, Ogada T, Beris P, et al. Haplotypes and Ó globin gene analyses in sickle cell anaemia patients from Kenya. Br J Haematol 1987; 65: 211–215
   PubMed Web of Science ®Google Scholar
• Onwubalili J K. Sickle cell disease and infection. J Infect 1983; 7: 2–20
   PubMed Web of Science ®Google Scholar
• Orringer E P, Blythe D S, Whitney J A, Brockenbrough S, Abraham D. Physiologic and rheologic effects of the antisickling agent ethacrynic acid and its n-butylated derivative on normal and sickle erythrocytes. Am J Hematol 1992; 39: 39–44
   Google Scholar
• Ortiz O E, Lew V L, Bookchin R M. Calcium accumulated by sickle cell anaemia red cells does not affect their potassium (86Rb+) flux components. Blood 1986; 67(3)710–715
   Google Scholar
• Palek J, Thomae D, Ozog D. Red cell calcium and transmembrane calcium movement in sickle cell anaemia. J Lab Clin Med 1977; 89: 1365–1374
   Google Scholar
• Pappo A, Buchanan G R. Acute splenic sequestration in a 2-month-old infant with sickle cell anaemia. Pediatrics 1989; 84(3)578–579
   Google Scholar
• Pauling L, Itano H A, Singer S J, Wells I C. Sickle cell anemia, a molecular disease. Science 1949; 110: 543–548
   PubMed Web of Science ®Google Scholar
• Pavlakis S G, Prohovnik I, Piomelli S, DeVivo D C. Neurologic complications of sickle cell disease. Adv Pediatr 1989; 36: 247–276
   PubMedGoogle Scholar
• Pearson H A, Spencer R P, Cornelius E A. Functional asplenia in sickle cell anemia. N Engl J Med 1969; 281(17)923–926
   PubMed Web of Science ®Google Scholar
• Pearson H A. Sickle cell anaemia and severe infections due to encapsulated bacteria. J Infect Dis 1977; 136: S25–S29, suppl
   PubMed Web of Science ®Google Scholar
• Pegelow C H, Pitel P, Judisch J. Guidelines for medical management of sickle cell disease. J Florida M A 1988; 751(11)734–741
   Google Scholar
• Perrine R P, Pembrey M E, John P, Perrine S, Shoup F. Natural history of sickle cell anemia in Saudi Arabs. Ann Intern Med 1978; 88(1)1–6
   PubMed Web of Science ®Google Scholar
• Phillips R E, Pasvol G. Anaemia of Plasmodium falciparum malaria. Bailliere's Clin Haematol 1992; 5(2)315–330
   Google Scholar
• Platt O S. Pathology of membrane proteins in sickle cell erythrocytes. Ann NY Acad Sci. 1989; 565: 83–85
   PubMedGoogle Scholar
• Platt O S. Is there treatment for sickle cell anaemia?. N Engl J Med 1988; 319(22)1479–1480
   Google Scholar
• Platt O, Thorington B C, Brambilla D T, et al. Pain in sickle cell disease: Rates and risk factors. N Engl J Med 1991; 325: 11–16
   PubMed Web of Science ®Google Scholar
• Powars D, Overturf G, Turner E. Is there an increased risk of Haemophilus influenzae septicemia in children with sickle cell anaemia?. Pediatrics 1983; 71(6)927–930
   Google Scholar
• Powars D R, Weiss J N, Chan L S, et al. Is there a threshold level of fetal haemoglobin that ameliorates morbidity in sickle cell anaemia?. Blood 1984; 63: 921–926
   PubMed Web of Science ®Google Scholar
• Powars D R. Sickle cell anaemia: β-gene-cluster haplotypes as prognostic indicators of vital organ failure. Seminars Hematol 1991; 28(3)202–208
   PubMed Web of Science ®Google Scholar
• Rank B H, Carlsson J, Hebbel R P. Abnormal redox status of membrane-protein thiols in sickle erythrocytes. J Clin Invest 1985; 75: 1531–1537
   PubMed Web of Science ®Google Scholar
• Rice-Evans C, Bruckdorfer K R, Dootson G. Studies on the altered membrane characteristics of sickle cells. FEBS Lett 1978; 94(1)81–86
   Google Scholar
• Rice-Evans C, Omorphos S C, Baysal E. Sickle cell membrane and oxidative damage. Biochem J 1986; 237: 265–269
   PubMed Web of Science ®Google Scholar
• Roelofsen B, Franck P FH, Chiu DT-Y, Lubin B, van Deenen L LM, Op den Kamp J AF. Sickled erythrocytes: a model to study the stabilization of the phospholipid bilayer in the red cell membrane. Biomed Biochim Acta 1983; 42(11/12)S22–S26
   Google Scholar
• Rowley P T. The diagnosis of beta-thalassemia trait: a review. Am J Hematol 1976; 1: 129–137
   PubMed Web of Science ®Google Scholar
• Rucknagel D L. Anemia and related syndromes. Arch Intern Med 1974; 33: 595–606
   Google Scholar
• Sears D A, Luthra M G. Membrane-bound hemoglobin in the erythrocytes of sickle cell anemia. J Lab Clin Med 1983; 102: 694–698
   PubMedGoogle Scholar
• Serjeant G R, Petch M C, Serjeant B E. The in vivo sickle phenomenon: A reappraisal. J Lab Clin Med 1973; 81(6)850–856
   Google Scholar
• Serjeant G R. Sickle cell disease. Oxford Medical Publications, Oxford 1988
   Google Scholar
• Sherman I W, Crandall I, Smith H. Membrane proteins involved in the adherence of Plasmodium falciparum infected erythrocytes to the endothelium. Biol Cell 1992; 74: 161–178
   PubMed Web of Science ®Google Scholar
• Smith J A. What do we know about the clinical course of sickle cell disease?. Seminars Hematol 1991; 28(3)209–212
   Google Scholar
• Steck T L. The organization of proteins in the human red blood cell membrane: a review. J Cell Biol 1974; 62: 1–19
   PubMed Web of Science ®Google Scholar
• Steck T L. The band 3 protein of the human red cell membrane: a review. J Supramol Struct 1978; 8: 311–324
   PubMedGoogle Scholar
• Steinberg M H, Hebbel R. Clinical diversity of sickle cell anaemia: Genetic and cellular modulation of disease severity. Am J Hematol 1983; 14: 405–416
   PubMed Web of Science ®Google Scholar
• Steingart R. Management of patients with sickle cell disease. Med Clin North Am 1992; 76(3)669–682
   PubMed Web of Science ®Google Scholar
• Strauss R G, Asbrock T, Forristal J, West C D. Alternative pathway of complement in sickle cell disease. Pediat Res 1977; 11: 285–289
   PubMed Web of Science ®Google Scholar
• Stuart J, Johnson C S. Rheology of the sickle cell disorders. Bailliere's Clin Haemat 1987; 1(3)747–775
   Google Scholar
• Tosteson D C, Shea E, Darling R C. Potassium and sodium of red blood cells in sickle cell anaemia. J Clin Invest 1952; 31: 406–411
   PubMed Web of Science ®Google Scholar
• Trowell H C, Raper A B, Welbourn H F. The natural history of homozygous sickle cell anaemia in central Africa. Quarterly J Med 1957; XXVI(104)401–422, New series
   Google Scholar
• Ueno H, Yatco E, Benjamin L J, Manning J. Effects of methyl acetyl phosphate, a covalent antisickling agent, on the density profiles of sickle erythrocytes. J Lab Clin Med 1992; 120: 152–158
   Google Scholar
• Vella F. Sickling in the Western Sudan. Sudan Med J 1964; 3(1)16–17
   Google Scholar
• Verani R R, Conley S B. Sickle cell glomerulopathy with focal segmental glomerulosclerosis. Child Nephrol Urol 1991; 11: 206–208
   Google Scholar
• Verkleij A J, Zwaal R FA, Roelofsen B, Comfurius P, Kastelijn D, van Deenen L LM. The asymmetric distribution of phospholipids in the human red cell membrane. Biochim Biophys Acta 1973; 323: 178–193
   PubMed Web of Science ®Google Scholar
• Wagner G, Chiu DT-Y, Schwatrs R S, Lubin B. Membrane phospholipid abnormalities in pathologic erythrocytes: a model for cell aging. Prog Clin Biol Res 1985; 195: 237–245
   Google Scholar
• Wahlefeld A W, Herz G, Bernt E. Modification of Malloy-Evelyn method for a simple, reliable determination of total bilirubin in serum. Scand J Clin Lab Invest. 1972; 29(suppl. 129)11–12
   Google Scholar
• Wallach D FH. Membrane and endoskeletal defects in HbSS erythrocytes. Prog Clin Biol Res 1981; 51: 333–353
   Google Scholar
• Waugh S M, Willardson B M, Kannan R, Labotka R J, Low P S. Heinz bodies induce clustering of band 3, glycophorin, and ankyrin in sickle cell erythrocytes. J Clin Invest 1986; 78: 1155–1160
   PubMedGoogle Scholar
• Weinstein R, Zhou M, Bartlett-Pandite A, Wenc K. Sickle erythrocytes inhibit human endothelial cell DNA synthesis. Blood 1990; 76(10)2146–2152
   Google Scholar
• Wilson W A, Jean Thomas E, Sissons J GP. Complement activation in asymptomatic patients with sickle cell anaemia. Clin exp Immunol 1979; 36: 130–139
   PubMed Web of Science ®Google Scholar
• Wilson W A. Nature of complement deficiency in sickle cell disease. Arch Dis Child 1983; 58(3)236–237
   Web of Science ®Google Scholar
• Winkelstein J A, Drachman R H. Deficiency of pneumococcal serum opsonizing activity in sickle cell disease. N Engl J Med 1968; 279(9)459–466
   Google Scholar
• Wong W-Y, Overturf G D, Powars D R. Infection caused by Streptococcus pneumoniae in children with sickle cell disease: Epidemiology, immunologic mechanisms, prophylaxis and vaccination. Clin Infect Dis 1992; 14: 1124–1136
   PubMed Web of Science ®Google Scholar
• Zail S. Clinical disorders of the red cell membrane skeleton. CRC Crit Rev Oncol/Hematol. 1986; 5: 397–453
   PubMedGoogle Scholar
• Zwaal R FA, Bevers E M, Comfurius P, Rosing J, Tilly R HJ, Verhallen P FJ. Loss of membrane phospholipid asymmetry during activation of blood platelets and sickled red cells; mechanisms and physiological significance. Mol Cell Biochem 1989; 91: 23–31
   PubMed Web of Science ®Google Scholar
• Archibald R G. A case of sickle cell anaemia in the Sudan. Trans R Soc Trop Med Hyg 1926; 19: 389–393
   Google Scholar
• Boghossian S H, Wright G, Webster A DB, Segal A W. Investigation of the host defence in patients with sickle cell disease. Br J Haematol 1985; 59: 523–531
   PubMed Web of Science ®Google Scholar
• Katsanis E, Hsu E, Luke K-H, McKee J A. Systemic lupus erythromatosus and sickle hemoglobinopathies: A report of two cases and review of the literature. Am J Hematol 1987; 25: 211–214
   PubMed Web of Science ®Google Scholar
• Hernandez D E, Gonzalez N, Rios R, Merchan L, Wuani H. Phagocytosis in patients with sickle cell disease. J Clin Lab Immunol 1983; 12: 137–140
   PubMedGoogle Scholar
• Donadi E A, Carvalho I F, Falcao R P. Circulating immune complexes in sickle cell anaemia. J Clin Lab Immunol 1989; 28: 183–185
   PubMedGoogle Scholar
• Backalew V M, Someren A. Renal manifestations of sickle cell disease. Arch Intern Med 1974; 133: 660–669
   PubMedGoogle Scholar
• Hussain M A, Mustafa M I, Kordofani A AY. Iron deficiency in Sudanese children with sickle cell anaemia. Saudi Med J 1991; 12(5)365–370
   Google Scholar
• Platt O S, Falcone J F, Lux S E. Molecular defect in the sickle erthrocyte skeleton, abnormal spectrin binding to sickle inside-out vesicles. J Clin Invest 1985; 75: 266–271
   PubMed Web of Science ®Google Scholar
• Davies S C, Brozovic M. The presentation, management and prophylaxis of sickle cell disease. Blood Rev 1989; 3: 29–44
   PubMed Web of Science ®Google Scholar
• Keidan A J, Sowter M C, Johnson C S, Marwah S S, Stuart J. Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease. Clin Sci. 1989; 76: 357–362
   Google Scholar
• Bailey K, Morris J S, Thomas P, Serjeant G R. Fetal haemoglobin and early manifestations of homozygous sickle cell disease. Arch Dis Child 1992; 67: 517–520
   PubMed Web of Science ®Google Scholar
• Nduke N, Ekeke G I. Serum calcium and protein in haemoglobin SS patients. Folia Haematol 1987; 4: 508–511
   Google Scholar